Morgan Stanley Novo Nordisk A S Transaction History

Morgan Stanley

$1.36 Trillion
Q1 2025

A detailed history of Morgan Stanley transactions in Novo Nordisk A S stock. As of the latest transaction made, Morgan Stanley holds 12,319,787 shares of NVO stock, worth $804 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

12,319,787

Previous 12,204,292 0.95%

Holding current value

$804 Million

Previous $1.05 Billion 18.51%

% of portfolio

0.06%

Previous 0.08%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$69.3 - $90.95 $8 Million - $10.5 Million	115,495 Added 0.95%	12,319,787 $855 Million
Q4 2024 Feb 14, 2025	SELL	$85.0 - $120.04 $184 Million - $259 Million	-2,161,110 Reduced 15.04%	12,204,292 $1.05 Billion
Q3 2024 May 14, 2025	SELL	$119.07 - $145.42 $29.2 Million - $35.7 Million	-245,498 Reduced 1.68%	14,365,402 $1.71 Billion
Q3 2024 Nov 14, 2024	SELL	$119.07 - $145.42 $29.2 Million - $35.7 Million	-245,498 Reduced 1.68%	14,365,402 $1.71 Billion
Q2 2024 May 14, 2025	BUY	$122.71 - $146.91 $295 Million - $354 Million	2,406,608 Added 19.72%	14,610,900 $2.09 Billion
Q2 2024 Oct 17, 2024	BUY	$122.71 - $146.91 $319 Million - $382 Million	2,599,047 Added 21.64%	14,610,900 $2.09 Billion
Q2 2024 Aug 14, 2024	BUY	$122.71 - $146.91 $319 Million - $382 Million	2,599,047 Added 21.64%	14,610,900 $2.09 Billion
Q1 2024 Oct 17, 2024	SELL	$102.11 - $135.92 $265 Million - $353 Million	-2,599,047 Reduced 17.79%	12,011,853 $1.54 Billion
Q1 2024 Aug 16, 2024	BUY	$102.11 - $135.92 $143 Million - $190 Million	1,397,042 Added 13.16%	12,011,853 $1.54 Billion
Q1 2024 May 15, 2024	BUY	$102.11 - $135.92 $143 Million - $190 Million	1,397,042 Added 13.16%	12,011,853 $1.54 Billion
Q4 2023 Aug 16, 2024	SELL	$87.78 - $105.45 $351 Million - $421 Million	-3,996,089 Reduced 27.35%	10,614,811 $1.1 Billion
Q4 2023 Feb 13, 2024	BUY	$87.78 - $105.45 $123 Million - $148 Million	1,399,713 Added 15.19%	10,614,811 $1.1 Billion
Q3 2023 Nov 15, 2023	BUY	$90.94 - $199.54 $412 Million - $903 Million	4,526,199 Added 96.53%	9,215,098 $838 Million
Q2 2023 Aug 14, 2023	BUY	$155.98 - $172.65 $13.4 Million - $14.9 Million	86,183 Added 1.87%	4,688,899 $759 Million
Q1 2023 May 15, 2023	SELL	$132.34 - $159.14 $80.7 Million - $97 Million	-609,682 Reduced 11.7%	4,602,716 $732 Million
Q4 2022 Feb 14, 2023	BUY	$102.55 - $135.33 $151 Million - $199 Million	1,472,550 Added 39.37%	5,212,398 $705 Million
Q3 2022 Nov 14, 2022	BUY	$95.28 - $116.93 $7.81 Million - $9.58 Million	81,942 Added 2.24%	3,739,848 $373 Million
Q2 2022 Oct 27, 2022	BUY	$103.24 - $121.81 $288 Million - $340 Million	2,792,217 Added 322.54%	3,657,906 $408 Million
Q2 2022 Aug 15, 2022	BUY	$103.24 - $121.81 $288 Million - $340 Million	2,792,217 Added 322.54%	3,657,906 $408 Million
Q1 2022 Oct 27, 2022	SELL	$93.1 - $112.54 $260 Million - $314 Million	-2,792,217 Reduced 76.33%	865,689 $96.1 Million
Q1 2022 May 13, 2022	SELL	$93.1 - $112.54 $6.99 Million - $8.45 Million	-75,113 Reduced 7.98%	865,689 $96.1 Million
Q4 2021 Feb 14, 2022	BUY	$95.88 - $117.08 $2.17 Million - $2.66 Million	22,677 Added 2.47%	940,802 $105 Million
Q3 2021 Nov 15, 2021	BUY	$84.42 - $106.62 $77.5 Million - $97.9 Million	918,125 New	918,125 $88.2 Million

Others Institutions Holding NVO

# of Institutions

1,762

Shares Held

340M

Call Options Held

11.3M

Put Options Held

15.5M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $147B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account